No Detail Found!

An effective combined therapy of meglumine antimoniate and co-trimoxazole for cutaneous leishmaniasis: A study in Quetta City.

Author(s)
Bilal Ahmed Department of Dermatology, Bolan Medical College, Quetta, Pakistan
Muhammad Iqbal Tareen Department of Dermatology, Bolan Medical College, Quetta, Pakistan
Ashok Kumar Department of Pathology, Isra University, Hyderabad, Pakistan
Saira Baloch Medical Research Centre, Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan
Hazir Rehman Medical Research Centre, Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan
Zahid Mustafa Centre for Advanced Studies in Vaccinology & Biotechnology (CASVAB), University of Baluchistan, Quetta, Pakistan
Abdul Malik Tareen Centre for Advanced Studies in Vaccinology & Biotechnology (CASVAB), University of Baluchistan, Quetta, Pakistan
Abstract
Objective To evaluate the efficacy of combined therapy of meglumine antimoniate and cotrimoxazole in cutaneous leishmaniasis (CL). Methods 180 patients with active lesions of CL, confirmed by fine needle aspiration cytology (FNAC) were treated with combined therapy of meglumine antimoniate (Glucantime) and cotrimoxazole (Septran) for 20 days. Results Out of 180 patients, 160 (88.9%) were cured. A few patients reported nausea, vomiting, glossitis, skin rashes and folate deficiency. Conclusion The combined therapy of meglumine antimoniate (Glucantime) and co-trimoxazole (Septran) is more effective than the previously reported combined therapies.
Publication Details
Page(s) 122-126
DOI DOI not available
Published Journal: Journal of Pakistan Association of Dermatologists, Volume: 24, Issue: 2, Year: 2014

Request the full text from PASTIC

0

Citations

0

Downloads

55

Views